We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+2.87%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$72.7B
AUM Growth
-$1.19B
Cap. Flow
-$1.73B
Cap. Flow %
-2.38%
Top 10 Hldgs %
14.67%
Holding
781
New
85
Increased
267
Reduced
290
Closed
88

Top Sells

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$661M
2
KEY icon
KeyCorp
KEY
+$549M
3
COP icon
ConocoPhillips
COP
+$399M
4
ABBV icon
AbbVie
ABBV
+$324M
5
UNP icon
Union Pacific
UNP
+$299M

Sector Composition

Rank Sector Weight
1 Financials 16.67%
2 Healthcare 15.9%
3 Technology 15.79%
4 Industrials 15.33%
5 Consumer Discretionary 9.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZO icon
1
AutoZone
AZO
$47.7B
$1.29B 1.78%
524,784
-4,186
-0.8% -$10.2M
BMY icon
2
Bristol-Myers Squibb
BMY
$126B
$1.25B 1.72%
18,080,568
+4,286,479
+31% +$302M
JPM icon
3
JPMorgan Chase
JPM
$930B
$1.24B 1.7%
9,467,438
-299,047
-3% -$41M
JNJ icon
4
Johnson & Johnson
JNJ
$624B
$1.18B 1.62%
7,594,495
-1,079,581
-12% -$174M
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$3.89T
$1.05B 1.45%
10,139,633
+2,181,905
+27% +$209M
CSCO icon
6
Cisco
CSCO
$444B
$1.03B 1.42%
19,828,729
+3,430,221
+21% +$168M
BRK.B icon
7
Berkshire Hathaway Class B
BRK.B
$1.06T
$977M 1.34%
3,151,483
-32,828
-1% -$10.1M
SNY icon
8
Sanofi
SNY
$104B
$976M 1.34%
17,945,943
-300,961
-2% -$14.6M
MPC icon
9
Marathon Petroleum
MPC
$91.2B
$861M 1.18%
6,409,473
-475,526
-7% -$59.5M
COR icon
10
Cencora
COR
$59.4B
$803M 1.1%
5,011,154
-190,334
-4% -$30.2M
SLB icon
11
SLB Ltd
SLB
$70.6B
$797M 1.1%
16,223,520
-1,145,335
-7% -$60.8M
UNH icon
12
UnitedHealth
UNH
$385B
$788M 1.08%
1,664,459
+94,962
+6% +$45.8M
HAL icon
13
Halliburton
HAL
$27.3B
$780M 1.07%
24,628,480
+12,228,234
+99% +$453M
HWM icon
14
Howmet Aerospace
HWM
$115B
$773M 1.06%
18,223,339
-2,716,274
-13% -$111M
KDP icon
15
Keurig Dr Pepper
KDP
$40.4B
$770M 1.06%
21,903,716
+960,316
+5% +$33.7M
CNP icon
16
CenterPoint Energy
CNP
$28.9B
$738M 1.01%
25,020,236
-112,517
-0.4% -$3.29M
CI icon
17
Cigna
CI
$75.7B
$731M 1%
2,860,633
-353,981
-11% -$103M
WFC icon
18
Wells Fargo
WFC
$261B
$704M 0.97%
18,749,526
+2,158,788
+13% +$94.1M
MCHP icon
19
Microchip Technology
MCHP
$44.2B
$694M 0.95%
8,303,250
+367,762
+5% +$29.3M
DD icon
20
DuPont de Nemours
DD
$18.6B
$665M 0.91%
7,390,119
-2,766,555
-27% -$252M
ICLR icon
21
Icon
ICLR
$13.1B
$656M 0.9%
3,077,298
-29,184
-0.9% -$6.49M
CPAY icon
22
Corpay
CPAY
$23.8B
$648M 0.89%
3,071,810
+774,730
+34% +$157M
ATVI
23
DELISTED
Activision Blizzard
ATVI
$645M 0.89%
7,575,149
+5,203,383
+219% +$404M
CCEP icon
24
Coca-Cola Europacific Partners
CCEP
$45.8B
$641M 0.88%
10,805,588
-166,555
-2% -$9.31M
DOV icon
25
Dover
DOV
$26.6B
$602M 0.83%
3,961,474
-575,449
-13% -$84.5M

Similar funds

Boston Partners's Q1 2023 Portfolio in Review

As of Q1 2023, Boston Partners held 781 positions worth $72.7B, down 1.6% from $73.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Boston Partners's Q1 2023 filing shows 85 new, 267 increased, 290 reduced and 88 closed positions. Its largest new stake was Arthur J. Gallagher & Co: 2,181,433 shares worth $419M. The largest sale was Charles Schwab, an estimated $661M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

  • Boston Partners's largest Q1 2023 buy was Arthur J. Gallagher & Co: 2,181,433 shares worth $419M.
  • Boston Partners added most to Halliburton in Q1 2023, an estimated $453M increase.
  • Boston Partners's biggest Q1 2023 reduction was Charles Schwab, cutting an estimated $661M.
  • Boston Partners fully exited Union Pacific in Q1 2023, selling an estimated $299M.
  • Boston Partners's ten largest holdings make up 15% of its $72.7B portfolio in Q1 2023.
  • Boston Partners opened 85 new positions and closed 88 in Q1 2023.
  • Boston Partners's portfolio value fell 1.6% quarter-over-quarter to $72.7B.

Based on Boston Partners's 13F filing for Q1 2023, filed 9 May 2023.